- Home
- MYSZ vs SYRS Comparison
MYSZ vs SYRS Comparison
Compare MYSZ & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYSZ
- SYRS
- Stock Information
- Founded
- MYSZ 1999
- SYRS 2011
- Country
- MYSZ Israel
- SYRS United States
- Employees
- MYSZ N/A
- SYRS N/A
- Industry
- MYSZ Computer Software: Prepackaged Software
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- MYSZ Technology
- SYRS Health Care
- Exchange
- MYSZ Nasdaq
- SYRS Nasdaq
- Market Cap
- MYSZ 8.2M
- SYRS 7.1M
- IPO Year
- MYSZ N/A
- SYRS 2016
- Fundamental
- Price
- MYSZ $2.07
- SYRS $0.21
- Analyst Decision
- MYSZ Strong Buy
- SYRS Hold
- Analyst Count
- MYSZ 1
- SYRS 5
- Target Price
- MYSZ $3.00
- SYRS $3.00
- AVG Volume (30 Days)
- MYSZ 8.2M
- SYRS 3.2M
- Earning Date
- MYSZ 11-14-2024
- SYRS 10-31-2024
- Dividend Yield
- MYSZ N/A
- SYRS N/A
- EPS Growth
- MYSZ N/A
- SYRS N/A
- EPS
- MYSZ N/A
- SYRS N/A
- Revenue
- MYSZ $9,632,000.00
- SYRS $386,000.00
- Revenue This Year
- MYSZ $35.62
- SYRS N/A
- Revenue Next Year
- MYSZ $12.88
- SYRS N/A
- P/E Ratio
- MYSZ N/A
- SYRS N/A
- Revenue Growth
- MYSZ 43.89
- SYRS N/A
- 52 Week Low
- MYSZ $1.05
- SYRS $0.18
- 52 Week High
- MYSZ $9.40
- SYRS $7.96
- Technical
- Relative Strength Index (RSI)
- MYSZ 42.86
- SYRS 36.45
- Support Level
- MYSZ $2.24
- SYRS $0.20
- Resistance Level
- MYSZ $3.15
- SYRS $0.25
- Average True Range (ATR)
- MYSZ 0.55
- SYRS 0.03
- MACD
- MYSZ -0.21
- SYRS 0.03
- Stochastic Oscillator
- MYSZ 1.35
- SYRS 11.73
About MYSZ My Size Inc.
My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.